Company profile
MeiraGTx Holdings plc
NASDAQ: MGTX · Healthcare · Biotechnology
#372 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
48DFH 47DQ 34GM 72SS 67
v0.1 · 65/100 weight · provisional
↑ 3-yr revenue growth, revenue growth (YoY) · ↓ disclosure history, balance-sheet leverage
Methodology →Revenue TTM
$79.8M
Rev growth YoY (TTM)
+131.1%
Net income (FY)
-$114.2M
Employees
409
as of 2026-08-10
Market cap
$1.2B
as of 2026-08-10
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$81.4M$81.4M2025
Net income-$114.2M-$114.2M2025
Operating income-$106.0M-$106.0M2025
Total assets$244.4M$244.4M2025
Liabilities$250.2M$250.2M2025
Equity-$5.8M-$5.8M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY20
FY21
FY21
FY24
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
License92%
Related Party Service Revenue8%
By geography
Not disclosed.
The read
What is MeiraGTx Holdings plc’s revenue?
MeiraGTx Holdings plc booked $81.4M in FY2025 revenue, growing 145% year over year — faster than most Healthcare companies we track, at a -140.3% net margin.
Peers · Healthcare
Nurix Therapeutics, Inc.53DIRadimed Corporation86AArcturus Therapeutics Holdings Inc.49DDecibel Cannabis Company Inc.62CTELA Bio, Inc.47DEton Pharmaceuticals, Inc.60CNeighbors
New York →Key facts
CEOAlexandria Forbes
SectorHealthcare
IndustryBiotechnology
HeadquartersNew York City, NY
ExchangeNASDAQ: MGTX
Employees409
IPO date2018-06-08
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.